Seniors in Medicare are about to get landmark obesity drug coverage
13 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Seniors in Medicare are about to get landmark obesity drug coverage" is generating significant coverage in the Business category, with 15 articles from 13 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Morning Brew, qz.com, The Washington Post and CNN. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 140d ago.
Quick answers
Why is "Seniors in Medicare are about to get landmark obesity drug coverage" trending?
Because 13 independent news sources published 15 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (15)
- Obesity drug access is about to expand via Medicare Morning Brew · 142d ago
- Medicare GLP-1 weight loss drug coverage starts July 2026 qz.com · 142d ago
- Medicare is about to cover GLP-1 drugs for weight loss. Here’s what to know. The Washington Post · 142d ago
- Medicare will start covering weight-loss drugs on July 1 for the first time. Here’s what you need to know CNN · 142d ago
- What Medicare Part D patients need to know about accessing Foundayo (orforglipron) and Zepbound (tirzepatide) for weight management investor.lilly.com · 142d ago
- A new Medicare option for weight loss drugs: What older Americans should know AOL.com · 142d ago
- A new Medicare option for weight loss drugs: What older Americans should know AOL.com · 142d ago
- Opinion - Dr. Oz’s GLP-1 Bridge could work, but it isn’t a model for price controls Yahoo · 142d ago
- Older Americans will soon have Medicare access to GLP-1s for weight loss for the first time. Here’s what they need to know. MarketWatch · 142d ago
- Seniors in Medicare are about to get landmark obesity drug coverage CNBC · 142d ago
- Dr. Oz’s GLP-1 Bridge could work, but it isn’t a model for price controls The Hill · 142d ago
- Medicare will soon offer some older Oregonians weight loss drugs for $50 a month. Here’s how it works OregonLive.com · 142d ago
- Medicare to cover Ozempic-style weight loss drugs for $50 a month starting July 1: Who qualifies MassLive · 142d ago
- Medicare to Cover GLP-1 Weight-Loss Drugs For $50 a Month: See If You’re Eligible TODAY.com · 142d ago
- Seniors in Medicare are about to get landmark obesity drug coverage CNBC · 142d ago
Topics
Related trends
'We feel blindsided': Minnesota seniors navigate unexpected Medicare cost increases
Medicare Advantage plan withdrawals and cost spikes are hitting seniors across multiple states ahead of 2027 enrollment changes.
Quest Diagnostics pays $13M to settle kickback allegations involving NY Giants tickets
Quest Diagnostics has paid $13 million to settle a federal lawsuit alleging it used New York Giants perks to secure patient referrals.
Your job-based insurance cut GLP-1 coverage. Here are some options
Insurers are cutting coverage for GLP-1 weight-loss drugs, with coverage dropping from 57% to 53% between 2025 and 2026, while list prices range from $500 to over $1,000 monthly.
Medicare Advantage vs. Traditional Medicare: What You Need to Know
Choosing between Medicare Advantage and Original Medicare involves critical trade-offs in costs, benefits, and provider networks.
CMS makes it official, codifying Medicare drug price negotiations established under IRA
CMS finalizes rule codifying Medicare drug price negotiations under the Inflation Reduction Act, advancing the program into its fourth negotiation cycle.
Woman scammed out of $3 million speaks after King County residents lose $4.6 million in gold bar schemes
A Shoreline woman speaks out after sophisticated gold bar scams cost Americans millions and target seniors.